PMCCPMCCPMCC

Search tips
Search criteria 

Advanced

 
Logo of pubhealthrepLink to Publisher's site
 
Public Health Rep. 1997 Jan-Feb; 112(1): 10–21.
PMCID: PMC1381831

The complicated task of monitoring vaccine safety.

Abstract

Vaccination is an essential component of modern public health programs and is among our most cost-effective medical interventions. Yet despite vaccines' clear effectiveness in reducing risks of diseases that previously attacked large proportions of the population, caused many deaths, and left many people with permanent disabilities, current vaccination policies are not without controversy. Vaccines, like all other pharmaceutical products, are not entirely risk-free; while most known side effects are minor and self-limited, some vaccines have been associated with very rare but serious adverse effects. Because such rare effects are often not evident until vaccines come into widespread use, the Federal government maintains ongoing surveillance programs to monitor vaccine safety. The interpretation of data from such programs is complex and is associated with substantial uncertainty. A continual effort to monitor these data effectively and to develop more precise ways of assessing risks of vaccines is necessary to ensure public confidence in immunization programs.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (7.2M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Prevots DR, Sutter RW, Strebel PM, Weibel RE, Cochi SL. Completeness of reporting for paralytic poliomyelitis, United States, 1980 through 1991. Implications for estimating the risk of vaccine-associated disease. Arch Pediatr Adolesc Med. 1994 May;148(5):479–485. [PubMed]
  • Kimura M, Kuno-Sakai H. Developments in pertussis immunisation in Japan. Lancet. 1990 Jul 7;336(8706):30–32. [PubMed]
  • Miller D, Madge N, Diamond J, Wadsworth J, Ross E. Pertussis immunisation and serious acute neurological illnesses in children. BMJ. 1993 Nov 6;307(6913):1171–1176. [PMC free article] [PubMed]
  • Krantz I, Taranger J, Trollfors B. Estimating incidence of whooping cough over time: a cross-sectional recall study of four Swedish birth cohorts. Int J Epidemiol. 1989 Dec;18(4):959–963. [PubMed]
  • Hinman AR. DTP vaccine litigation. Am J Dis Child. 1986 Jun;140(6):528–530. [PubMed]
  • Mariner WK, Clark ME. Confronting the immunization problem: proposals for compensation reform. Am J Public Health. 1986 Jun;76(6):703–708. [PubMed]
  • Flamberg G. An experiment in Tort reform. Public Health Rep. 1995 Sep-Oct;110(5):635–638. [PMC free article] [PubMed]
  • Chen RT, Rastogi SC, Mullen JR, Hayes SW, Cochi SL, Donlon JA, Wassilak SG. The Vaccine Adverse Event Reporting System (VAERS). Vaccine. 1994 May;12(6):542–550. [PubMed]
  • Kessler DA. Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems. JAMA. 1993 Jun 2;269(21):2765–2768. [PubMed]
  • Kessler DA. Introducing MEDWatch. A new approach to reporting medication and device adverse effects and product problems. JAMA. 1993 Jun 2;269(21):2765–2768. [PubMed]
  • Faich GA. Adverse-drug-reaction monitoring. N Engl J Med. 1986 Jun 12;314(24):1589–1592. [PubMed]
  • Stetler HC, Mullen JR, Brennan JP, Livengood JR, Orenstein WA, Hinman AR. Monitoring system for adverse events following immunization. Vaccine. 1987 Sep;5(3):169–174. [PubMed]
  • Niu MT, Davis DM, Ellenberg S. Recombinant hepatitis B vaccination of neonates and infants: emerging safety data from the Vaccine Adverse Event Reporting System. Pediatr Infect Dis J. 1996 Sep;15(9):771–776. [PubMed]
  • Hoffman HJ, Hunter JC, Damus K, Pakter J, Peterson DR, van Belle G, Hasselmeyer EG. Diphtheria-tetanus-pertussis immunization and sudden infant death: results of the National Institute of Child Health and Human Development Cooperative Epidemiological Study of Sudden Infant Death Syndrome risk factors. Pediatrics. 1987 Apr;79(4):598–611. [PubMed]
  • Hoffman HJ, Hillman LS. Epidemiology of the sudden infant death syndrome: maternal, neonatal, and postneonatal risk factors. Clin Perinatol. 1992 Dec;19(4):717–737. [PubMed]
  • Ponsonby AL, Dwyer T, Gibbons LE, Cochrane JA, Wang YG. Factors potentiating the risk of sudden infant death syndrome associated with the prone position. N Engl J Med. 1993 Aug 5;329(6):377–382. [PubMed]
  • Klonoff-Cohen HS, Edelstein SL, Lefkowitz ES, Srinivasan IP, Kaegi D, Chang JC, Wiley KJ. The effect of passive smoking and tobacco exposure through breast milk on sudden infant death syndrome. JAMA. 1995 Mar 8;273(10):795–798. [PubMed]
  • Wigfield RE, Fleming PJ, Berry PJ, Rudd PT, Golding J. Can the fall in Avon's sudden infant death rate be explained by changes in sleeping position? BMJ. 1992 Feb 1;304(6822):282–283. [PMC free article] [PubMed]
  • Dwyer T, Ponsonby AL, Blizzard L, Newman NM, Cochrane JA. The contribution of changes in the prevalence of prone sleeping position to the decline in sudden infant death syndrome in Tasmania. JAMA. 1995 Mar 8;273(10):783–789. [PubMed]
  • Mitchell EA, Brunt JM, Everard C. Reduction in mortality from sudden infant death syndrome in New Zealand: 1986-92. Arch Dis Child. 1994 Apr;70(4):291–294. [PMC free article] [PubMed]
  • Spiers PS, Guntheroth WG. Recommendations to avoid the prone sleeping position and recent statistics for sudden infant death syndrome in the United States. Arch Pediatr Adolesc Med. 1994 Feb;148(2):141–146. [PubMed]
  • Berry GT, Prantner JE, States B, Yandrasitz JR. The effect of glucose and galactose toxicity on myo-inositol transport and metabolism in human skin fibroblasts in culture. Pediatr Res. 1994 Feb;35(2):141–147. [PubMed]
  • Willinger M. Sleep position and sudden infant death syndrome. JAMA. 1995 Mar 8;273(10):818–819. [PubMed]
  • Rosenthal S, Chen R, Hadler S. The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment. Arch Pediatr Adolesc Med. 1996 May;150(5):457–460. [PubMed]
  • Rosenthal S, Chen R, Hadler S. The safety of acellular pertussis vaccine vs whole-cell pertussis vaccine. A postmarketing assessment. Arch Pediatr Adolesc Med. 1996 May;150(5):457–460. [PubMed]
  • Chen RT, Haber P, Mullen JR. Surveillance of the safety of simultaneous administration of vaccines. The Centers for Disease Control and Prevention experience. Ann N Y Acad Sci. 1995 May 31;754:309–320. [PubMed]
  • Rosenthal S, Chen R. The reporting sensitivities of two passive surveillance systems for vaccine adverse events. Am J Public Health. 1995 Dec;85(12):1706–1709. [PubMed]
  • Strom BL, Carson JL. Use of automated databases for pharmacoepidemiology research. Epidemiol Rev. 1990;12:87–107. [PubMed]

Articles from Public Health Reports are provided here courtesy of Association of Schools of Public Health